Clinical Trial Update: Vitamin D3 for Moderate to Mild Traumatic Brain Injury: A Randomized Trial on Inflammation and Recovery (VIMOT) [Phase 2]

View source ↗

Summary

Phase 2 randomized trial (VIMOT) evaluating vitamin D3 (cholecalciferol) for reducing neuroinflammation and promoting recovery after moderate to mild traumatic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Drugs mentioned

• Vitamin D3 (Cholecalciferol)

Snippet

Sponsor: Lagos State University | Conditions: Traumatic Brain Injury (TBI) Patients, Neuroinflammation | Phase 2 | Status: NOT_YET_RECRUITING